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Cellular lipids determine membrane integrity and fluidity and are being increasingly recognized to influence immune 
responses. Cellular cholesterol requirements are fulfilled through biosynthesis and uptake programs. In an intricate 
pathway involving the lysosomal cholesterol transporter NPC1, the sterol gets unequally distributed across intracellular 
compartments. By using pharmacological and genetic approaches targeting NPC1, we reveal that blockade of cholesterol 
trafficking through the late endosome–lysosome pathway blunts NLRP3 inflammasome activation. Altered cholesterol 
localization at the plasma membrane (PM) in Npc1−/− cells abrogated AKT–mTOR signaling by TLR4. However, the inability 
to activate the NLRP3 inflammasome was traced to perturbed cholesterol trafficking to the ER but not the PM. Accordingly, 
acute cholesterol depletion in the ER membranes by statins abrogated casp-1 activation and IL-1β secretion and ablated 
NLRP3 inflammasome assembly. By contrast, assembly and activation of the AIM2 inflammasome progressed unrestricted. 
Together, this study reveals ER sterol levels as a metabolic rheostat for the activation of the NLRP3 inflammasome.
Trafficking of cholesterol to the ER is required for 
NLRP3 inflammasome activation
Marianne de la Roche1*, Claire Hamilton1*, Rebecca Mortensen1, A. Arockia Jeyaprakash2, Sanjay Ghosh3, and Paras K. Anand1
Introduction
The inflammasome is a multiprotein complex that plays critical 
roles in infectious, inflammatory, and autoimmune diseases. The 
NLRP3 inflammasome is the most characterized inflammasome 
in terms of the diverse stimuli that are known to activate it. Acti-
vation of the NLRP3 inflammasome requires assembly of NLRP3 
and caspase-1 (casp-1) bridged together through the adaptor pro-
tein ASC, wherein casp-1 undergoes autoproteolytic processing. 
Subsequently, active casp-1 cleaves precursor forms of cytokines 
interleukin (IL)–1β and IL-18, which can then be secreted (Man 
and Kanneganti, 2015; Hamilton et al., 2017). Casp-1 also cleaves 
gasdermin D (GSD MD), making its N-terminal pore-forming do-
main active, leading to cell rupture (Kayagaki et al., 2015; Shi et 
al., 2015). Distinct exogenous, endogenous, and environmental 
stimuli are known to activate the NLRP3 inflammasome, imply-
ing that these stimuli do not bind NLRP3 directly but likely con-
verge on shared upstream pathways. The mechanistic details of 
NLRP3 activation remain ambiguous.
Lipids are known to carry out diverse functions within cells, 
including being a major component of cell membranes, and as 
signaling messengers. Cholesterol is an essential lipid in mam-
malian cell membranes aiding varied functions, the most funda-
mental of which are membrane integrity and fluidity (Maxfield 
and Tabas, 2005). Levels of cholesterol in the cell are maintained 
through de novo synthesis in the ER, and uptake of low-density 
lipoproteins (LDLs) derived from dietary cholesterol. Excess free 
cholesterol can be toxic to cells; thus, sterol homeostasis needs 
to be integrated by a combination of cholesterol uptake, biosyn-
thesis, and efflux programs. At the subcellular level, cholesterol 
follows an intricate pathway in cells (Ikonen, 2008). Exogenously 
obtained LDL bound to LDL receptor is internalized at the plasma 
membrane (PM) and is transported through the endocytic path-
way to the late endosomes–lysosomes, where cholesterol esters 
within the LDL core are hydrolyzed by acid lipases. Unesterified 
or free cholesterol translocates through the lysosomal cholesterol 
transporter Niemann-Pick C1 (NPC1) to other cellular sites such 
as the PM and the ER. In the ER, cholesterol can be reesterified, 
permitting cytoplasmic storage in the form of lipid droplets.
Until recently, cholesterol has mostly been accepted to have an 
influence on immunity during pathological conditions such as in 
atherosclerosis (Fessler, 2016). However, evidence suggests that 
homeostatic lipid metabolism and trafficking directly regulate 
the inflammatory pathways in macrophages. For example, de-
fective lipid trafficking in the absence of NPC1 leads to the lyso-
somal storage disorder Niemann-Pick disease (Platt et al., 2012). 
Mutations in the cholesterol efflux transporter, ABCA1, give rise 
to signs and symptoms of Tangier disease (Fasano et al., 2012). 
Similarly, perturbations in lipid metabolism contribute to several 
human pathologies including cardiovascular, obesity, and neuro-
degenerative diseases (Maxfield and Tabas, 2005). In addition to 
contributing to the pathogenesis of several diseases, cholesterol 
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is also exploited by pathogens for their entry and proliferation 
within host cells. Several pathogens that lack the capacity for de 
novo sterol synthesis use cholesterol for their survival and repli-
cation by either increasing host lipid biosynthesis or redirecting 
cholesterol transport pathways (Coppens et al., 2000; Lauer et 
al., 2000; Carabeo et al., 2003; Kaul et al., 2004; Ilnytska et al., 
2013). These studies suggest that reducing lipid synthesis may 
serve to limit nutrients available to pathogens, thus benefitting 
host cells. Conversely, host cells need lipids for mounting a ro-
bust immune response to infection through conserved pattern 
recognition receptors (Castrillo et al., 2003; York et al., 2015). 
Together, these studies lead to the hypothesis that lipid homeo-
stasis is critical for an effective inflammatory response with im-
plications for homeostatic lipid trafficking in both infectious and 
inflammatory diseases. Whether perturbations in homeostatic 
cholesterol trafficking pathway impact inflammasome activation 
remains unknown.
In this study, by using pharmacological and genetic tools, 
we demonstrate that selective perturbation of the cellular cho-
lesterol trafficking in macrophages ablates inflammasome ac-
tivation. Mechanistically, perturbed sterol trafficking in Npc1 
deficiency leads to two distinct effects: altered PM cholesterol 
levels resulted in inhibition of the AKT–mTOR pathway, while 
reduced cholesterol trafficking to the ER blunted NLRP3 inflam-
masome assembly. Accordingly, acute cholesterol depletion in the 
ER by statins decreased IL-1β secretion, which could be restored 
by supplementing with exogenous cholesterol. Our findings thus 
implicate sterol synthesis and distribution as critical factors in-
fluencing the activation of the inflammasome, thereby coupling 
lipid homeostasis to innate immune signaling.
Results
Lysosomal sterol accumulation dampens 
inflammasome activation
Homeostatic cholesterol trafficking is important as its distribu-
tion among subcellular organelles upholds vital housekeeping 
functions, and is critically dependent on lysosomal cholesterol 
transporter NPC1. The lysosomal egress of cholesterol can be 
blocked by exposing cells to a cationic amphiphile and an andro-
stenolone derivative, U18666a, which specifically targets NPC1 
(Lu et al., 2015). To assess the effect of U18666a on cholesterol 
transport in our experiments, we first exposed bone marrow–de-
rived mouse macrophages (BMDMs) and immortalized BMDMs 
(iBMDMs) to the compound and examined cholesterol localiza-
tion by staining with a naturally fluorescent polyene antibiotic, 
filipin. Filipin specifically binds to free cholesterol in biologi-
cal membranes and can be excited by UV fluorescence. Filipin 
staining of control cells revealed diffused cholesterol staining 
throughout the cell (Fig. S1). By contrast and in conformity with 
previous studies in different cell types, exposure of BMDMs 
and iBMDMs to U18666a resulted in punctate structures remi-
niscent of lysosomes, thus demonstrating lysosomal cholesterol 
accumulation (Fig. S1, A and B; Strauss et al., 2010; Maxfield 
and Wüstner, 2012). Notably, these punctate structures were 
completely absent in control cells. Furthermore, we observed no 
significant difference in total cholesterol levels in untreated and 
lipopolysaccharide (LPS)–treated cells in the presence or absence 
of U18666a, suggesting that the elevated cholesterol accumula-
tion in lysosomes is a result of altered sterol trafficking (Fig. 1 A). 
Together, these results established lysosomal cholesterol accu-
mulation in mouse macrophages exposed to U18666a.
Next, to investigate the impact of cellular sterol trafficking 
on inflammasome activation, we exposed control and U18666a-
treated BMDMs to LPS and ATP stimulation, a canonical ligand 
for activating the NLRP3 inflammasome. Activation of the NLRP3 
inflammasome results in cleavage of pro–casp-1 to its active 
form, which subsequently processes precursor forms of cyto-
kines IL-1β and IL-18 to their biologically active forms. Exposure 
of LPS-primed control cells to ATP resulted in robust casp-1 ac-
tivation, which was significantly abolished in cells where cho-
lesterol distribution was restricted to lysosomes (Fig.  1  B). In 
agreement, this was accompanied with significant reduction in 
IL-1β secretion compared with control cells (Fig. 1 C). To assess 
the specificity of this response, we next performed these exper-
iments in BMDMs exposed to a range of U18666a concentrations 
followed by LPS and ATP stimulation. In confirmation with our 
above results, this resulted in a dose-dependent decrease in both 
casp-1 activation and secretion of inflammasome-dependent cy-
tokines IL-1β and IL-18 (Fig. 1, D–F). Finally, we confirmed these 
results with itraconazole, an antifungal drug that retards cho-
lesterol trafficking from lysosomes. Similar to the results with 
U18666a, exposure to itraconazole resulted in reduced casp-1 ac-
tivation and IL-1β secretion (Fig. S1 C). The precise mechanism by 
which itraconazole blocks cholesterol trafficking is not known. 
However, previous research established filipin colocalization 
with lysosomes but not PM, ER, and mitochondrial markers in 
endothelial cells exposed to the antifungal agent (Xu et al., 2010). 
Overall, these studies validated defective cholesterol trafficking 
as the cause of dampened inflammasome activation.
Activation of inflammasome is characterized by cell swell-
ing and subsequent osmotic lysis in the form of pyroptotic cell 
death following GSD MD cleavage (Kayagaki et al., 2015; Shi et 
al., 2015). In control cells primed with either LPS or Pam3, stim-
ulation with ATP caused pyroptotic cell death. However, upon 
exposure to U18666a, cell death, and thus the secreted levels 
of cytosol-localized cell death marker, lactate dehydrogenase 
(LDH), were markedly diminished (Fig.  1, G–I). Overall these 
results demonstrate reduced casp-1 activation, IL-1β and IL-18 
secretion, and decreased pyroptosis when cellular cholesterol 
trafficking is inhibited.
Impaired cholesterol trafficking but not lysosomal dysfunction 
dampens inflammasome activation
Because of their propensity to accumulate lipids, NPC1 mutant 
cells demonstrate impaired phagosome maturation (Huynh et al., 
2008), autophagy (Sarkar et al., 2013), and defective NOD2-me-
diated microbial clearance (Schwerd et al., 2016). These studies 
prompted us to investigate whether lysosomal dysfunction in 
NPC1 mutant cells could account for defective inflammasome 
activation. To address this, we took advantage of vacuolar-type 
H+-ATPase inhibitor Bafilomycin A1 (Baf A1), which prevents 
phagosome–lysosome fusion, and chloroquine diphosphate (CQ), 
an inhibitor of lysosomal acidification. Exposure of LPS-primed 
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Figure 1. Lysosomal sterol accumulation dampens inflammasome activation. (A) BMDMs were incubated with U18666a in the presence or absence of LPS followed 
by measurement of total cholesterol. (B) BMDMs were either left untreated or exposed to 5 µg/ml U18666a before treating them with LPS (500 ng/ml; 4 h) and ATP 
(5 mM; 45 min). Cell lysates were immunoblotted for casp-1 antibody, and GAP DH was used as loading control. (C) IL-1β release from cells treated as above. (D) BMDMs 
were either left untreated or exposed to increasing concentrations of U18666a (1, 2, 5, and 10 µg/ml) before stimulating them with LPS and ATP. (E and F) Cell lysates were 
immunoblotted for the antibodies indicated, and cell supernatants were analyzed for IL-1β (E) or IL-18 (F) by ELI SA. (G) Microscopy images of cells treated as above in B 
or with Pam3 (500 ng/ml; 4 h) followed by ATP. Arrows show characteristic pyroptotic cell death. Bars, 20 µm. (H and I) LDH release in supernatants from cells treated 
as in G. (J and K) LPS-primed BMDMs treated with indicated concentrations of Baf A1 (J) or CQ (K) followed by ATP. Data shown are mean ± SD, and experiments shown 
are representative of at least three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, by Student’s t test. 
Journal of Cell Biology
https://doi.org/10.1083/jcb.201709057
de la Roche et al. 
ER sterol levels modulate the NLRP3 inflammasome
3563
cells to either of these during the last 1 h of priming resulted in 
comparable IL-1β secretion, dismissing reduced inflammasome 
activation as a secondary outcome of elevated lysosomal choles-
terol accumulation (Fig. 1, J and K).
We next performed experiments to determine the role of prim-
ing in our assays. Activation of the NLRP3 inflammasome requires 
two signals. The first signal, which potentiates the NLRP3 inflam-
masome, is provided upon Toll-like receptor (TLR) ligation and 
results in the synthesis of pro–IL-1β and up-regulation of NLRP3 
expression (Anand et al., 2011a). This first signal (also known as 
the priming step) is dependent on the transcription factor NF-κB 
(Bauernfeind et al., 2009; Hornung and Latz, 2010). The second 
signal, which is more robustly provided by purinergic receptor 
P2X7 agonist ATP, results in the assembly of NLRP3, casp-1, and 
adaptor protein ASC to form a multiprotein complex (Pelegrin 
and Surprenant, 2006). One potential explanation for defective 
inflammasome activation observed in experiments above could 
be the reduced priming of the NLRP3 inflammasome when ste-
rol trafficking is perturbed. First, we demonstrate that the above 
results were not solely limited to TLR4 pathway as exposure of 
U18666a-treated BMDMs to TLR2 agonist Pam3CSK4 followed 
by ATP stimulation also resulted in abolition of casp-1 activation 
and IL-1β secretion (Fig. S1, D and E). As expected, these results 
were entirely dependent on NLRP3 as Nlrp3−/− iBMDMs displayed 
blunted casp-1 activation and IL-1β production in cells exposed to 
inflammasome agonist nigericin (Fig. S1, F and G). Second, there 
was no reduction in the expression levels of NLRP3 and the se-
creted levels of the inflammasome-independent cytokine TNF-α, 
which are both transcriptionally up-regulated, and the adaptor 
ASC, when homeostatic cholesterol trafficking was abolished by 
pharmacological treatment in cells primed with either LPS or 
Pam3 (Figs. 1 D and S1, D, H, I, and J). On the contrary, a modest in-
crease in NLRP3 and secreted levels of TNF-α was observed, likely 
because of elevation in TLR signaling upon cholesterol accumula-
tion (Yvan-Charvet et al., 2007; Zhu et al., 2008, 2012). However, 
this did not directly correlate with transcript levels in our study, 
which were found comparable, indicating an as yet unknown 
mechanism for posttranscriptional increase (Fig. S1, K–M). Taken 
together, these data excluded defective lysosomal function and 
priming as the reason for diminished NLRP3 activation.
Deficiency in Npc1 abrogates NLRP3 inflammasome activation
Cholesterol egress from lysosomes is directly dependent on sterol 
transporter NPC1. Next, to validate our results in a genetic model, 
we generated Npc1-deficient iBMDMs using the CRI SPR-Cas9 ap-
proach (see Materials and methods; Fig. S2). Two independent 
clonal cell lines were obtained that showed deletion of variable 
lengths at the Npc1 locus as validated by Sanger sequencing (Fig. 
S2, A and B). Reverse transcription–quantitative PCR (RT-qPCR) 
analysis showed that compared with WT cells, the Npc1 mRNA 
levels in both clonal cell lines were significantly reduced (Fig. S2 
C). Moreover, in agreement with the known function of NPC1, 
both mutant cell lines exhibited cholesterol accumulation in dis-
tinct punctate structures as revealed by filipin staining (Fig. 2 A). 
Thus, we concluded that CRI SPR-Cas9 targeting resulted in defi-
ciency of NPC1 activity, and therefore, the mutations are genuine 
loss-of-function alleles.
Exposure of LPS-primed WT cells to inflammasome ago-
nist nigericin resulted in the maturation of 45 kD pro–casp-1 
to 20 kD active casp-1. However, activation of casp-1 was ab-
lated in Npc1-deficient cells (Fig. 2 B). In agreement, IL-1β and 
IL-18 release was also significantly abolished in Npc1-deficient 
cells (Fig. 2, C and D). As seen with the pharmacological inhib-
itor, there was a modest increase in NLRP3 expression in Npc1- 
deficient cells, while secretion of the inflammasome-indepen-
dent cytokine TNF-α remained unaffected (Fig.  2, B and E). 
Activation of cells with LPS + ATP reiterated defective casp-1 
activation and IL-1β release in Npc1-deficient cells, while 
TNF-α secretion remained unaffected (Fig.  2, F–H). Further-
more, Npc1-deficient cells were remarkably protected from cell 
death (Fig. 2 I). These results thus establish both pharmacolog-
ical and genetic knockout of Npc1 as valid approaches to block 
cholesterol lysosomal egress, and furthermore, they implicate 
NPC1-dependent cellular sterol trafficking as pivotal for the ac-
tivation of the NLRP3 inflammasome.
Lysosomal sterol efflux is not required for the activation of 
NLRC4 and AIM2 inflammasomes
A diverse array of signals is known to activate the NLRP3 inflam-
masome. In contrast, ligands that activate the NLRC4 and AIM2 
inflammasomes are well defined. The NLRC4 inflammasome is 
triggered by the recognition of cytosolic flagellin and compo-
nents of the bacterial secretion system by upstream NAIP fam-
ily members (Amer et al., 2006; Kofoed and Vance, 2011; Zhao 
et al., 2011). AIM2 inflammasome, in contrast, is activated by 
recognition of double-stranded DNA of ∼80 bp in length (Jin 
et al., 2012). We next tested whether the requirement for ho-
meostatic cholesterol transport is specific to the activation of 
the NLRP3 inflammasome. First, we tested whether lysosomal 
sterol accumulation affects NLRC4 inflammasome activation by 
infecting macrophages with Salmonella typhimurium. Unlike 
NLRP3, casp-1 activation by the NLRC4 inflammasome remained 
unaffected in cells where NPC1 was pharmacologically blocked 
(Fig. 3 A). In agreement, Npc1−/− cells also demonstrated casp-1 
activation and IL-1β secretion comparable with that observed in 
infected WT cells (Fig. 3, B and C). We next evaluated whether the 
DNA sensing AIM2 inflammasome is affected by sterol lysosomal 
compartmentalization. To evaluate this, WT cells (in the pres-
ence or absence of U18666a) and Npc1−/− cells were transfected 
with poly(dA:dT). Western blotting revealed no impact on casp-1 
activation upon poly(dA:dT) transfection when lysosomal egress 
of cholesterol was blocked (Fig. 3 D). These results demonstrate 
that sterol lysosomal compartmentalization uniquely affects the 
NLRP3 inflammasome.
Cholesterol compartmentalization dampens GSD 
MD-mediated ASC-independent pyroptosis following NLRC4 
inflammasome activation
Activation of the inflammatory caspases (including casp-1) re-
sults in the cleavage of GSD MD to remove the autoinhibitory 
C-terminal fragment. The resulting active N-terminal cleavage 
product oligomerizes to form membrane pores to trigger pyro-
ptosis (Kayagaki et al., 2015; Shi et al., 2015; Ding et al., 2016). 
Previous research demonstrated that induction of pyroptosis, 
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Figure 2. Deficiency in Npc1 abrogates NLRP3 inflammasome activation. (A) Confocal microscopy images of WT and Npc1−/− iBMDMs stained with filipin. 
Note that two different clonal cells lines of Npc1−/− (#1, #2) are shown. Bars, 10 µm. (B–E) WT and Npc1−/− cells were either left untreated or treated with LPS 
(500 ng/ml; 4 h) and nigericin (20 nM; 45 min). Cell lysates were immunoblotted for antibodies indicated (B), and cell supernatants were analyzed for IL-1β, 
IL-18, and TNF-α by ELI SA (C–E). (F–H) WT and Npc1−/− cells were either left untreated or treated with LPS (500 ng/ml; 4 h) and ATP (5 µM; 45 min). Cell lysates 
were immunoblotted for antibodies indicated (F), and cell supernatants were analyzed for IL-1β and TNF-α by ELI SA (G and H). (I) Microscopy images of cells 
treated as above in B showing characteristic pyroptotic cell death. Bars, 20 µm. Data shown are mean ± SD, and experiments shown are representative of at 
least three independent experiments. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, by Student’s t test. 
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as demonstrated by LDH release during NLRC4 inflammasome 
activation by S. typhimurium, is ASC-independent but casp-1–
dependent. Surprisingly, NLRC4-dependent pyroptosis pro-
gressed in the absence of casp-1 autoproteolysis (Broz et al., 
2010). We therefore took advantage of these studies to assess 
whether sterol lysosomal efflux influenced the induction of 
ASC-independent pyroptosis. As observed above, blockade of 
cholesterol transport in WT cells did not inhibit casp-1 activa-
tion by S. typhimurium infection (Fig. 3 A). Accordingly, cleavage 
of GSD MD was also similar when NPC1 was pharmacologically 
blocked in WT cells (Fig. 3 E). In agreement with previous re-
search (Broz et al., 2010), pyroptosis, and thus GSD MD N-ter-
minal fragment, was not observed in casp-1/11−/− cells but was 
cleaved in Asc−/− cells comparably with WT cells (Fig. 3 E). Sur-
prisingly, Asc−/− cells treated with U18666a exhibited reduced 
GSD MD cleavage, suggesting a role for homeostatic cholesterol 
transport in pyroptosis only in the absence of ASC (Fig.  3  E). 
By contrast, cholesterol accumulation had no effect on GSD MD 
cleavage either in U18666a-treated or in Npc1−/− cells following 
AIM2 inflammasome activation by poly(dA:dT) transfection 
(Fig. 3 D). Conversely, GSD MD cleavage was reduced following 
NLRP3 inflammasome activation with both LPS + ATP and Pam3 
+ ATP, mirroring the effects seen on casp-1 activation (Fig. 3, F 
and G). These data thus suggest that cholesterol lysosomal egress 
is required for ASC-independent pyroptosis following NLRC4 ac-
tivation. However, pyroptosis following activation of the AIM2 
inflammasome is not affected.
Cholesterol supplementation restores 
inflammasome activation
Variation in the levels of cholesterol and other lipids within 
the cell are sensed by master transcriptional regulators SRE BP1 
and SRE BP2, which, respectively regulate fatty acid and choles-
terol biosynthesis (Horton et al., 2002). A feedback mechanism 
tightly regulates cholesterol de novo biosynthesis to maintain 
homeostatic levels. Cholesterol depletion triggers ER resident 
sterol cargo protein SCAP to escort SRE BP2 to the Golgi, where 
the precursor is cleaved to activate cholesterogenic genes. By 
Figure 3. Npc1 deficiency does not affect 
the activation of NLRC4 and AIM2 inflam-
masomes. (A) WT iBMDMs were incubated with 
or without the presence of increasing concen-
trations of U18666a (2, 5, and 10 µg/ml) along-
side Nlrc4−/− cells and subsequently infected 
with S. typhimurium at an MOI of 2 for ∼4  h. 
Cell lysates were immunoblotted for casp-1 and 
GAP DH. (B) WT and Npc1−/− cells were treated 
with S. typhimurium for 4  h and immunoblot-
ted as in A. (C) Cell supernatants were analyzed 
for IL-1β. (D) WT cells either treated or not with 
U18666a (5 µg/ml) and Npc1−/− cells were trans-
fected with poly(dA:dT) for 4 h before cell lysates 
were immunoblotted for the antibodies indi-
cated. (E) WT, Asc−/−, and caspase 1/11−/− cells 
were exposed or not to U18666a before infection 
with S. typhimurium as above. Cell lysates were 
immunoblotted for GSD MD and GAP DH. (F and 
G) BMDMs were treated with either LPS (500 ng/
ml; 4 h) or Pam3 (500 ng/ml; 4 h) in the pres-
ence of increasing concentrations of U18666a 
(1, 2, 5, and 10 µg/ml) followed by ATP (5 mM; 
45 min). Cell lysates were immunoblotted for 
GSD MD and GAP DH.
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contrast, in cholesterol-replete cells, conformational change in 
SCAP promotes insulin-induced gene–mediated retention of 
SRE BP2 in the ER.
Low ER cholesterol is an established trigger for SRE BP2 ac-
tivation. Although the movement of cholesterol from the NPC1 
compartment to the PM and to the ER is defective in cells lacking 
functional NPC1 (Cruz et al., 2000; Sugii et al., 2003), the total 
cholesterol levels were not considerably elevated when NPC1 was 
pharmacologically blocked (Fig. 1 A). To investigate this further, 
we quantified SRE BP2 targets hydroxymethylglutaryl (HMG)-
CoA synthase (Hmgcs1) and HMG-CoA reductase (Hmgcr) in 
LPS-primed cells, and the transcript levels were significantly 
down-regulated in Npc1−/− cells (Fig. S2, D–F). Intriguingly, the 
expression of Srebp2 was also reduced in Npc1-deficient cells, 
thereby reconfirming previous research showing that SRE BP2 
autoregulates its own mRNA expression (Sato et al., 1996). The 
decreased expression of SRE BP2-dependent genes likely also 
results in reduced nuclear localization of the mature protein as 
correlation has been observed in other studies (Repa et al., 2000; 
Im et al., 2011). The levels of Srebp2 and the target gene Hmgcs1 
were elevated in control Npc1−/− cells (Fig. S4 A).
SRE BP-dependent lipogenesis is regulated by mTORC1, a 
master regulator of cellular metabolism (Porstmann et al., 2008; 
Peterson et al., 2011). By evaluating the phosphorylation of ribo-
somal protein p70 S6 kinase 1 (S6K1), a direct mTOR substrate, 
we investigated the upstream pathway that modulates SRE BP2 in 
our study. Npc1−/−- and U18666a-exposed cells displayed reduced 
phosphorylation of S6K1 and the upstream mTOR regulator ser-
ine/threonine protein kinase AKT (protein kinase B) in cells 
exposed to LPS in a time-course experiment (Fig. S3). The de-
crease in the activation of AKT–mTOR pathway is likely a result 
of disorganized lipid raft microdomains in the PM of Npc1−/− cells 
(Simons and Toomre, 2000; Vainio et al., 2005). Accordingly, 
Npc1−/− cells exhibited reduced PM cholesterol levels as measured 
by its susceptibility to cholesterol oxidase (Fig. S4 B). Indeed, re-
duction in PM cholesterol in WT cells by methyl-β-cyclodextrin 
(MCD) treatment resulted in reduced mTOR activity (unpub-
lished data). Furthermore, inhibition of mTOR by selective in-
hibitor Torin1 significantly decreased the expression of Srebp2 
and the target genes Hmgcs1 and Hmgcr (Fig. S2, G–I). The reg-
ulation of SRE BP2 by mTOR is well established and involves the 
phosphatidic acid phosphatase lipin-1, which functions at several 
steps to control SRE BP activity (Peterson et al., 2011). These re-
sults demonstrate reduced mTOR- and SRE BP2-dependent lipo-
genesis in Npc1−/− cells following LPS stimulation.
Since our observations above suggested overall reduction in 
cholesterol in subcellular organelles, we reasoned that supple-
mentation with exogenous cholesterol should restore inflam-
masome activity. To conduct these experiments, MCD-solubilized 
cholesterol was added to LPS-primed cells cultured in serum-free 
medium 1 h before ATP treatment to assess only the effects on 
the second signal of inflammasome activation. Remarkably, sup-
plementation with soluble cholesterol restored inflammasome 
activation in cells where lysosomal egress of cholesterol was 
pharmacologically blocked, resulting in a distinct increase in 
both casp-1 cleavage and IL-1β secretion (Fig. 4, A and B). The 
addition of cholesterol–MCD complex to LPS-primed cells in the 
absence of ATP was insufficient to activate the inflammasome, 
while exposure to alum resulted in abundant IL-1β secretion, 
suggesting the crystal-independent nature of cholesterol–
MCD-induced NLRP3 inflammasome (Fig. 4, B and C). Similarly, 
cholesterol–MCD by itself was insufficient at providing “signal 
1” in the absence of LPS (Fig. 4, A and B). Npc1−/− cells supple-
mented with exogenous cholesterol–MCD reiterated elevated 
IL-1β secretion (Fig. 4 D). Also, this response appeared to be con-
centration dependent, with the optimal concentration of choles-
terol peaking at ∼15 µg/ml (Fig. 4, E and F). Collectively, these 
results demonstrate that replenishment with soluble cholesterol 
in cells with nonfunctional NPC1 restores casp-1 activation and 
IL-1β production.
Cholesterol depletion in the ER membranes abrogates casp-1 
activation and IL-1β secretion
We next investigated the subcellular site to which the cholesterol 
must localize for optimal inflammasome activity. To address this, 
we first focused on the PM, which is the largest pool of cholesterol 
in the cell, where it makes up 50–60% of total lipids (Ridsdale et 
al., 2006). To measure the contribution of PM, we took advan-
tage of a routinely used cholesterol extraction agent, MCD, to de-
plete PM cholesterol from cells cultured in lipoprotein-deficient 
serum. We recognized from our experiments above that changes 
to the PM cholesterol affect AKT–mTOR signaling. Therefore, 
to eliminate the involvement of other pathways and to specif-
ically address the role of PM cholesterol in the second step of 
inflammasome activation, we exposed LPS-primed BMDMs to 
MCD only for 30 min before ATP stimulation. We reasoned that 
restricted exposure to MCD would affect only the PM cholesterol 
while retaining the architecture of other cellular cholesterol 
pools (Ridsdale et al., 2006). As expected, exposure to MCD re-
sulted in reduction in total cholesterol levels by ∼60% (Fig. 5 A). 
However, subsequent treatment with ATP did not affect casp-1 
activation or IL-1β release (Fig. 5, B and C), excluding any role for 
PM cholesterol in inflammasome activation.
The transport of cholesterol from the NPC1 compartment to 
the ER is blunted in cells lacking functional NPC1 (Cruz et al., 
2000; Sugii et al., 2003). In agreement, Npc1−/− cells exhibited 
diminished levels of esterified cholesterol (Fig. 5 D). Therefore, 
we next examined the role of cholesterol in the ER membranes, 
which are cholesterol poor, with only 3–6% of total lipids. To 
specifically deplete cholesterol in the ER, we took advantage of 
the fact that cells grown in lipoprotein-deficient serum depend 
entirely on endogenous cholesterol synthesis to support growth 
(Ridsdale et al., 2006). We therefore exposed LPS-primed cells to 
statins, specific inhibitors of cholesterol biosynthetic pathway, to 
cause acute cholesterol depletion of the ER pool. Statin treatment 
initially decreases cholesterol specifically in the ER membranes; 
therefore, we restricted statin treatment to only 1 h before ATP 
stimulation. In agreement with its function, exposure of control 
cells to fatostatin resulted in reduced expression of SRE BP2 and 
the target genes (Fig. S4 C). Inflammasome activation in cells 
exposed to fatostatin resulted in significantly reduced IL-1β se-
cretion (Fig. 5 E). Similarly, treatment with lovastatin and me-
vastatin, which target HMG-CoA reductase, the rate limiting 
enzyme of cholesterol synthesis, also resulted in reduced casp-1 
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cleavage and IL-1β secretion upon NLRP3 activation (Fig.  5, F 
and G). Conversely, addition of either cholesterol–MCD or meva-
lonate, the direct product of HMG-CoA reductase, to the media of 
statin-exposed cells restored IL-1β secretion (Fig. 5 H and Fig. S4 
D). Statin treatment, however, affected only the NLRP3 inflam-
masome. Exposure of cells grown in lipoprotein-deficient media 
to lovastatin during the last 1 h of AIM2 inflammasome activa-
tion by poly(dA:dT) transfection did not affect casp-1 activation 
(Fig. 5 I). Consequently, secretion of IL-18 was also comparable 
regardless of the presence of lovastatin during poly(dA:dT) trans-
fection (Fig. 5 J). As expected, the secretion of IL-18 and IL-1β was 
significantly diminished during LPS and ATP stimulation (Fig. 5, 
J and K). These observations unequivocally demonstrate that ER 
cholesterol is required for the NLRP3 inflammasome activation.
ER cholesterol depletion blunts ASC-dependent 
inflammasome assembly
Activation of inflammasome and IL-1β secretion is critically 
dependent on the assembly of the supramolecular complex 
containing NLRP3, ASC, and casp-1. The assembly of this com-
plex is quite elaborate and requires the release to the cytoplasm 
of mitochondria-associated ER membrane (MAM)-localized 
Figure 4. Cholesterol supplementation restores inflammasome activation in cells defective in NPC1 function. (A) BMDMs were either left untreated 
or exposed to LPS and cholesterol–MCD complexes (chol), cholesterol and ATP, or LPS and ATP in the presence or absence of 5 µg/ml U18666a. Where added, 
cells were incubated with 15 µg/ml cholesterol for 1 h before ATP treatment. Samples were immunoblotted with casp-1, and GAP DH was used as a loading 
control. (B) Cell supernatants were analyzed for secreted IL-1β by ELI SA. Bar graph shows percent IL-1β restoration when cholesterol–MCD was added. 
(C) IL-1β levels in LPS-primed BMDMs grown in complete DMEM and exposed to alum (1 mg/ml). (D) IL-1β levels in Npc1−/− cells either left untreated or treated 
with LPS and cholesterol–MCD for 1 h followed by ATP. (E) BMDMs were either left untreated or exposed to LPS and ATP in the presence or absence of 5 µg/ml 
U18666a. Where added, cells were incubated with indicated concentrations of cholesterol–MCD for 1 h before ATP treatment. Samples were immunoblotted 
with the indicated antibodies. GAP DH was used as a loading control. (F) Cell supernatants from above were analyzed for secreted IL-1β by ELI SA. Bar graph 
shows percent IL-1β restoration when cholesterol–MCD was added. Data shown are mean ± SD, and experiments shown are representative of at least three 
independent experiments. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, by Student’s t test.
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Figure 5. Cholesterol depletion in the ER membranes abrogates casp-1 activation and IL-1β secretion. (A) Total cholesterol levels in control or LPS 
treated BMDMs in the presence or absence of MCD. (B and C) BMDMs were treated as in A followed by the addition of ATP. Cell lysates were immunoblotted 
for casp-1 (B), and supernatants were analyzed for IL-1β (C). (D) WT and Npc1−/− cells were treated with LPS (500 ng/ml; 4 h) before measurement of esterified 
cholesterol. (E and G) IL-1β levels in LPS-primed BMDMs exposed to fatostatin (E), lovastatin, or mevastatin (G) for 1 h before the addition of ATP. (F) Casp-1 
immunoblotting of cell lysates treated as described above and indicated. (H) Secreted IL-1β levels upon addition of cholesterol–MCD for 1 h before ATP stim-
ulation from BMDM treated as above in G. (I) BMDMs were either treated with LPS + ATP or transfected with poly(dA:dT) (1 µg/ml; 4 h) in the presence or 
absence of lovastatin (40 µM) during the final 1 h. Cell lysates were immunoblotted for the antibodies indicated. (J and K) Cells were treated as in I, and cell 
supernatants were analyzed for IL-18 (J) and IL-1β (K). Data shown are mean ± SD, and experiments shown are representative of at least three independent 
experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, by Student’s t test.
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NLRP3, which in the presence of the activating stimuli, nucle-
ates the ASC filament, believed to be a major determinant for 
inflammasome assembly and the downstream cellular func-
tions of inflammasomes. ASC, a bipartite protein composed of a 
PYD and a CARD domain, acts as an adaptor protein linking the 
PYD-containing NLRP3 to the CARD-containing casp-1 through 
homotypic interactions. Upon receptor activation, ASC oligom-
erizes to form the so-called ASC speck, a macromolecular com-
plex that is ∼1–2 µm in diameter. Under resting conditions, ASC 
is present diffusely throughout the cytoplasm. Stimulation of 
the NLRP3 inflammasome with LPS + ATP was sufficient to as-
semble the inflammasome, resulting in ASC speck formation in 
control WT cells (Fig. 6 A). However, ASC speck formation was 
significantly abolished both in Npc1−/− cells and in cells where 
NPC1 was pharmacologically blocked by U18666a (Fig. 6, A and 
B). We next independently verified whether ER cholesterol de-
pletion by statin treatment could also blunt the assembly of the 
NLRP3 inflammasome. As before, we grew BMDMs in lipopro-
tein-deficient media and depleted ER cholesterol by exposing 
LPS-primed cells to lovastatin for 1 h before ATP stimulation. In 
response to NLRP3 agonist ATP, control cells revealed expected 
levels of ASC speck formation. However, the percentage of cells 
showing ASC specks was significantly reduced in samples treated 
with lovastatin (Fig. 6, C and E). Similarly, control cells exposed 
to AIM2 agonist poly(dA:dT) demonstrated ASC speck formation. 
However, in contrast to the NLRP3 inflammasome, ER choles-
terol depletion by exposure to lovastatin during the last 1 h of 
poly(dA:dT) transfection did not influence the assembly of the 
AIM2 inflammasome (Fig. 6, D and E). These results thus suggest 
that NLRP3 complex formation is distinctly regulated by the ER 
cholesterol pool.
NLRP3 recruitment to ASC is diminished in Npc1-deficient cells
Biochemical evidence suggests that NLRP3 is mainly localized on 
MAMs, thus positioning NLRP3 in close proximity to mitochon-
dria-released effectors, many of which are known to activate the 
NLRP3 inflammasome (Nakahira et al., 2011; Zhou et al., 2011; Iyer 
et al., 2013; Lupfer et al., 2013, 2014; Wang et al., 2013; Gurung et 
al., 2015). On the contrary, the majority of the ASC is found in the 
cytoplasmic fraction before inflammasome activation, although 
a minor portion of ASC is found associated with the ER fraction 
(Zhou et al., 2011). However, the fully active inflammasome com-
plex is mostly cytoplasmic, suggesting the requirement of addi-
tional steps in the activation of the inflammasome (Zhou et al., 
2011; Wang et al., 2013). Intriguingly, the described distribution 
of the activating receptor is specific to the NLRP3 inflammasome, 
while localization of non-NLRP3 inflammasomes remains less 
characterized. We next tested the localization of NLRP3. In agree-
Figure 6. ER cholesterol depletion blunts 
ASC-dependent inflammasome assembly. 
(A) WT (control), U18666a-treated, and Npc1−/− 
cells were exposed to LPS + ATP followed by 
labeling with anti-ASC antibody and DAPI stain-
ing. (B) Quantitative analysis of percentage of 
cells with ASC specks in samples treated as 
above. Each dot represents an individual field 
with at least n = 40 cells. (C and D) LPS-primed 
BMDMs exposed to ATP (C) or poly(dA:dT)-trans-
fected BMDMs (D) were exposed or not to lovas-
tatin (40 µM; 1 h) followed by labeling with anti-
ASC antibody and DAPI staining. (E) Quantitative 
analysis of percentage of cells with ASC specks in 
samples treated as above. Each dot represents 
an individual field with at least n = 30 cells. Data 
shown are mean ± SEM, and experiments shown 
are representative of at least three independent 
experiments. Arrowheads show ASC specks. 
Bars, 5 µm. ****, P < 0.0001, by Student’s t test.
Journal of Cell Biology
https://doi.org/10.1083/jcb.201709057
de la Roche et al. 
ER sterol levels modulate the NLRP3 inflammasome
3570
ment with previous studies (Zhou et al., 2011; Zhang et al., 2017), 
control LPS-primed cells exhibited a fraction of NLRP3 close to 
MAMs as revealed by double labeling with the ER marker cal-
reticulin (Fig. S5 A). Upon subsequent exposure to ATP, NLRP3 
was found strongly associated to ASC in WT cells (Fig. 7, A and B). 
However, this was significantly diminished in Npc1−/− cells, where 
NLRP3 and ASC were both found diffusely localized throughout 
the cell (Fig. 7, C and D). Quantitative analysis revealed a signifi-
cation reduction in NLRP3 association with ASC in Npc1-deficient 
cells (Fig. 7 E). As expected, the assembled inflammasome did not 
show significant association with ER, while mitochondria were 
found in close proximity (Fig. S5 B). However, in agreement with 
another study (Zhou et al., 2011), ASC speck was found associated 
with mitochondria and ER in a fraction of cells. Our study thus 
suggests that ER cholesterol is pivotal for recruitment of NLRP3 to 
ASC and thus full activation of the NLRP3 inflammasome. Over-
all, our data suggest that cholesterol acts as a rheostat to modulate 
NLRP3 activity, and thus these studies may be useful to develop 
novel therapeutics to treat NLRP3-related disorders.
Discussion
Our study demonstrates that homeostatic sterol trafficking and 
distribution provide an appropriate intracellular milieu for the 
activation of the NLRP3 inflammasome. Pharmacological or ge-
netic blockade of NPC1 blunted NLRP3 inflammasome activa-
tion, resulting in reduced casp-1 activation and IL-1β secretion 
in response to NLRP3 agonists. Remarkably, cellular cholesterol 
trafficking uniquely affects the NLRP3 inflammasome, while 
activation of the NLRC4 and AIM2 inflammasomes remained 
unimpeded. Further mechanistic research suggested that cho-
lesterol trafficking to the ER licenses the NLRP3 inflammasome 
activation. In agreement, acute depletion of the ER cholesterol 
pool by statin treatment abrogated the assembly and activation 
of the NLRP3 inflammasome.
A previous study associated inflammasome activation to di-
etary cholesterol (Progatzky et al., 2014). These authors observed 
an increase in the accumulation of myeloid cells in the intestine 
of zebrafish that were fed a high-cholesterol diet, which was 
found to be dependent on cholesterol uptake by PM–localized 
Figure 7. NLRP3 recruitment to ASC is 
diminished in Npc1−/− cells. (A and C) WT and 
Npc1−/− cells were exposed to LPS + ATP and sub-
sequently fixed and labeled for NLRP3 and ASC 
with secondary antibodies conjugated to FITC 
and Alexa Fluor 546, respectively. Inset shows 
zoom of indicated regio n on the middle panel. 
Bars, 10 µm. (B and D) Profile of fluorescence 
intensity along the indicated white bar in inset 
in A and C, respectively. (E) Quantitative anal-
ysis showing the percentage of cells that show 
NLRP3 and ASC association. At least 10 random 
fields were selected each with n = 15 cells. Data 
shown are mean ± SD, and experiments shown 
are representative of at least three independent 
experiments. ****, P < 0.0001, by Student’s t 
test. (F and G) Schematic model describing the 
identified mechanism in the activation of the 
NLRP3 inflammasome. (F) Homeostatic cellular 
cholesterol trafficking to the ER is required for 
optimal inflammasome activation. Exogenously 
obtained LDL bound to LDL-R is endocytosed at 
the PM. Cholesterol efflux from the late endo-
some–lysosome compartment to other cellular 
sites such as the PM and the ER is dependent on 
NPC1. (G) Blockade of the cholesterol transporter 
NPC1 leads to lysosomal cholesterol accumula-
tion and a subsequent decrease in cholesterol 
pool in both the ER and the PM. This in turn leads 
to decreased phosphorylation of AKT and mTOR 
following TLR ligation, causing a reduction in 
SRE BP2-dependent lipogenesis. Additionally, 
perturbation in the ER cholesterol levels leads 
to decreased association of NLRP3 and ASC, 
resulting in reduced active casp-1 levels and IL-1β 
secretion. Furthermore, inhibition of ER choles-
terol levels by statins similarly blunts NLRP3 
inflammasome activation. LDL-R, low-density 
lipoprotein receptor; mTOR, mammalian target 
of rapamycin; SRE BP2, sterol regulatory element 
binding protein 2.
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NPC1-like 1 (NPC1L1). Inhibitors of both NPC1L1 and inflam-
masome components reduced the accumulation of myeloid cells. 
This study thus provided evidence that cholesterol uptake by 
NPC1L1 is able to activate the inflammasome (i.e., provide “sig-
nal 2”). However, inflammasome activation by cholesterol uptake 
was restricted to intestinal epithelial cells, with no role identified 
for hematopoietic cells (Progatzky et al., 2014). In agreement, 
NPC1L1 is expressed predominately in the gastrointestinal tract, 
whereas lysosomal NPC1 is more abundantly expressed in a wide 
variety of cells and tissues (Altmann et al., 2004). Our study sig-
nifying the role of macrophage sterol trafficking in NLRP3 acti-
vation thus unravels distinct mechanisms of NPC1 and NPC1L1 in 
modulating inflammasome in discrete cell types.
Previous studies have highlighted a role for cholesterol 
in NLRP3 inflammasome activation during atherosclerosis 
(Duewell et al., 2010; Rajamäki et al., 2010; Freigang et al., 2011; 
Sheedy et al., 2013). Mice fed an atherogenic diet displayed cho-
lesterol crystal formation as early as 2 wk in atherosclerotic le-
sions, which correlated with macrophage recruitment (Duewell 
et al., 2010). The inflammasome activation in the above research 
was dependent on macrophage lysosomal rupture and subse-
quent cathepsin B release into the cytoplasm following accumu-
lation of cholesterol crystals within the degradative organelle 
(Hornung et al., 2008). Whether cellular cholesterol trafficking 
directly impacts inflammasome activation remained unknown. 
Our data demonstrate that blockade of cholesterol trafficking 
through NPC1 dampened the NLRP3 inflammasome, which could 
be restored by addition of exogenous cholesterol. These findings 
are in agreement with a recently published study in which exog-
enous cholesterol was shown to activate the AIM2 inflammasome 
(Dang et al., 2017). However, in their study, cells were exposed 
to cholesterol–MCD for 8 h, which eventually resulted in mito-
chondrial dysfunction and increased cytosolic mitochondrial 
DNA content. Thus, inflammasome activation in their research 
was dependent on DNA sensor AIM2. However, we exposed mac-
rophages for only 1 h with cholesterol–MCD followed by a canon-
ical NLRP3 stimulus, ATP, thereby implicating a role for NLRP3 
inflammasome in our study. Together, these studies demonstrate 
that cholesterol function in distinct organelles modulates differ-
ent inflammasomes.
In cells lacking functional NPC1, the movement of cholesterol 
from the NPC1 compartment to the ER and to the PM is defective 
(Sugii et al., 2003; Wojtanik and Liscum, 2003). In agreement, 
Npc1−/− cells exhibited both reduced levels of esterified choles-
terol and decreased sensitivity to cholesterol oxidase. Thus, Npc1 
deficiency alters PM order and composition, thereby affecting 
discrete cholesterol-dependent signaling networks localized in 
lipid rafts (Simons and Ehehalt, 2002). This is most likely the 
reason for both the reduced activation of the AKT–mTOR–SRE 
BP2 axis and a modest increase in Npc1−/− cells of the NLRP3 ex-
pression, the latter agreeing with elevated TLR signaling when 
cellular sterol efflux is blocked (Zhu et al., 2008). However, it is 
difficult to reconcile these data at the moment, considering that 
contrasting responses were observed with signal emanating 
from the same TLR4 receptor. However, our data would imply an 
unidentified posttranscriptional mechanism for enhanced TLR 
responses upon cholesterol accumulation.
We found a key role for the ER cholesterol pool in inflam-
masome activation, while deviation in the PM cholesterol levels 
did not affect casp-1 activation and IL-1β secretion. Our model 
suggesting a significant role for ER cholesterol agrees with previ-
ous studies (Fig. 7). Inhibition of SRE BP processing by 25-hydroxy 
cholesterol results in reduced IL-1β production (Reboldi et al., 
2014). Likewise, BMDMs lacking SCAP, which chaperones SRE 
BP2 to the Golgi for processing, exhibit reduced casp-1 activation 
and IL-1β expression (Reboldi et al., 2014). Under resting condi-
tions, NLRP3 is mainly localized on MAMs (Zhou et al., 2011), 
which are cholesterol poor and sensitive to changes in cholesterol 
levels. NLRP3 release from MAMs is necessary to oligomerize 
with cytoplasmic ASC when a second signal is available (Zhou 
et al., 2011; Wang et al., 2013; Zhang et al., 2017). ER is known to 
influence innate immune signaling, but the underlying mecha-
nisms remain unclear (Toulmay and Prinz, 2011; Misawa et al., 
2017). Together with our data, this raises an intriguing possibility 
that ER lipid composition might play a direct or indirect func-
tion in modulating immune responses, including the activation 
of inflammasome.
We observed a significantly reduced association of NLRP3 
and cytoplasmic ASC in Npc1−/− cells, suggesting that cholesterol 
likely provides fluidity to the ER membranes to allow NLRP3 re-
lease and subsequent assembly of an active inflammasome. How-
ever, at this time, it is difficult to rule out the additional roles 
of ER cholesterol upstream of the inflammasome assembly for-
mation and NLRP3 activation. For example, ER cholesterol may 
be required to provide the necessary conformation to NLRP3 to 
sense the activating effectors. Similarly, ER cholesterol might also 
enable NLRP3 association with ASC by allowing the extension 
of the ER tubules before the dissociation of the complex from 
the ER. In agreement with this, a fraction of cells displayed ASC 
specks that exhibited association with calreticulin (not depicted). 
Furthermore, in the latter scenario, cholesterol might also have 
a direct role in inflammasome assembly. It will be interesting 
to dissect the precise roles of ER cholesterol in inflammasome 
assembly and activation in future studies. Overall, our study 
reveals an essential requirement for sterol trafficking to the ER 
for the activation of the NLRP3 inflammasome. The results pre-
sented in our study may provide clues to develop novel treatment 
avenues for diseases where dysregulated lipid metabolism is the 
underlying factor.
Materials and methods
Ethics statement
Experiments were performed in accordance with the Animals 
(Scientific Procedures) Act 1986 and were approved by the Im-
perial College Animal Welfare and Ethical Review Body and the 
UK Home Office.
BMDM culture
C57BL/6 mice were obtained from Charles River. Bone marrow 
cells were isolated from 6–10-wk-old mouse femurs and tibias 
as previously described (Anand et al., 2011b) and allowed to 
differentiate into macrophages in DMEM containing 10% heat- 
inactivated FBS, 1% penicillin/streptomycin, 1% Hepes, and 30% 
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conditioned media from L929 fibroblasts. The cells were allowed 
to differentiate for 5–6 d at 37°C. After being harvested, cells for 
some experiments were grown in media containing 5% lipo-
protein-deficient serum as indicated. WT, Nlrp3−/−, Asc−/−, and 
Casp1/11−/− iBMDMs were provided by K. Fitzgerald (University 
of Massachusetts Medical School, Worcester, MA), T.-D. Kanneg-
anti (St. Jude Children's Research Hospital, Memphis, TN), and C. 
Bryant (University of Cambridge, Cambridge, UK). iBMDMs were 
cultured in DMEM containing 10% FBS, 1% penicillin/streptomy-
cin, and 10% L929 conditioned medium in 10-cm2 tissue culture 
plates. Cells were grown until confluent and split every 2–3 d.
Cell stimulations
Primary BMDMs and iBMDMs were seeded in 24-, 12-, or six-well 
plates at a density of 0.5 × 106, 1 × 106, or 2 × 106 cells per well, re-
spectively. Experiments with U18666a (662015; EMD Millipore) 
were optimized in different cell types so as to block lysosomal 
efflux of cholesterol and achieve absolute lysosomal accumula-
tion. Primary BMDMs exposed to U18666a displayed lysosomal 
cholesterol accumulation at 48 h, while in iBMDMs, sufficient 
cholesterol accumulation was observed by 24 h (Fig. S1). Where 
used, cells were exposed to Torin1 (CAY10997; Cayman Chemical) 
for 3 h, and Baf A1 (Sigma-Aldrich) and CQ (Sigma-Aldrich) at the 
indicated concentrations for 1 h before ATP stimulation.
Inflammasome activation assays
For NLRP3 activation, cells were primed with 500 ng/ml of either 
LPS (tlrl-pbslps; Invivogen) or Pam3 (tlrl-pms; Invivogen) for 4 h 
followed by addition of either 5 mM ATP (A6419; Sigma-Aldrich) 
or 20 nM nigericin (4312; Tocris) for 45 min. Cell images were 
taken using a light microscope following addition of either ATP 
or nigericin. Alum was used at 1 mg/ml for 16 h in LPS-primed 
cells grown in complete media. For NLRC4 activation, cells were 
infected with S. typhimurium strain SL1344 (gift from J. Galan 
[Yale University School of Medicine, New Haven, CT] and A. She-
noy [Imperial College London, London, UK]) at a MOI of 2 for 
∼4 h. For AIM2 inflammasome activation, cells grown in 24-well 
plates were transfected with 1 µg of poly(dA:dT) using Lipofect-
amine 2000 (Invitrogen) according to the manufacturer’s recom-
mendations. Following each condition, cell supernatants were 
collected and immediately frozen for cytokine analysis, and the 
cell lysates were harvested in radioimmunoprecipitation assay 
(RIPA) lysis buffer for immunoblot analysis.
Generation of CRI SPR-Cas9 targeting constructs
The CRI SPR design tool (http:// crispr .mit .edu) was used to iden-
tify two candidate gRNA sequences (compatible with Strepto-
coccus pyogenes Cas9 and its protospacer-adjacent motif [PAM; 
5′-NGG]) near the 5′ region of the mouse Npc1 gene (GenBank 
Accession no. NM_008720). 5′-phosphorylated oligonucleotides 
containing the gRNA sequences (underlined) and BbsI adapter 
are as follows: gRNA1 (5′-CAC CGCGA CCC GAG CGT CGC GGC AC-3′ 
and its reverse complement 5′-AAACGTG CCG CGA CGC TCG GGT 
CGC-3′) and gRNA2 (5′-CAC CGTCG GAA CCG GCG CCT GAC CA-3′ 
and its reverse complement 5′-AAACTGG TCA GGC GCC GGT TCC 
GAC-3′). The gRNA1 and gRNA2 oligonucleotides were annealed 
and ligated into pSpCas9(BB)-2A-GFP plasmid (48138; Addgene) 
at the BbsI restriction site as described (Ran et al., 2013). This 
allows constitutive expression of sgRNAs under the U6 promoter, 
while SpCas9 and GFP are expressed by the CBh promoter as 
two separate proteins due to the intervening self-cleaving T2A 
peptide. The recombinant plasmids (pSpCas9(BB)-2A-GFP-
Npc1_gRNA1 and pSpCas9(BB)-2A-GFP-Npc1_gRNA2) were PCR-
screened using the U6 promoter sequence and respective gRNA1 
or gRNA2 sequence as a reverse primer. Additionally, they were 
sequence-verified using a U6 promoter primer (5′-ATT TCT TGG 
GTA GTT TGC AG-3′).
Transfection, selection, and validation of Npc1 mutant lines
iBMDMs were transfected with 500 ng of pSpCas9(BB)-2A-GFP-
Npc1_gRNA1 and pSpCas9(BB)-2A-GFP-Npc1_gRNA2 separately 
using 1.5 µl transfection reagent (Xfect; Takara Bio Inc.) in 600 µl 
OptiMEM media (Invitrogen) at 37°C. After 6 h, the OptiMEM 
transfection mixtures were replaced with DMEM growth media 
supplemented with 10% FBS and 2% penicillin/streptomycin. 
Cells were incubated at 37°C in 5% CO2 for 48 h. The transfected 
cells were analyzed for expression of GFP (proxy for Cas9 expres-
sion) using a fluorescent microscope.
Flow cytometry–based analysis and cell sorting were per-
formed using the FACS Aria II (BD) to select Cas9-expressing 
cells. 48  h after transfection, the cells were trypsinized, har-
vested, and resuspended in Sorting Buffer (PBS supplemented 
with 2 mM EDTA and 0.1% BSA). Cells expressing Cas9 (GFP-pos-
itive) were isolated by FACS (single-cell sorting) and expanded in 
a 96-well plate.
Approximately 2 wk after transfection, genomic DNA of hy-
bridoma cell lines was prepared from typically 106 cells by using 
the GenElute Mammalian Genomic DNA Miniprep Kit (G1N70; 
Sigma-Aldrich). PCR amplification was performed with primers 
flanking the sgRNA targeted region (forward, 5′-CTT CCT GCC 
TTG CGC ACAC-3′, and reverse, 5′-CTG TCC CTG GCT AAC TGT GG-
3′) with the following cycling conditions: initial denaturation 
5 min at 95°C, 35 cycles with denaturation at 95°C (30 s), anneal-
ing at 60°C (45 s), elongation at 68°C (45 s), and final elongation 
at 68°C for 5 min. An aliquot (1:10) of the PCR product was ana-
lyzed by agarose gel electrophoresis; the rest of the samples were 
purified using Monarch PCR & DNA Cleanup Kit (T1030; New 
England Biolabs, Inc.) and sequenced (Fig. S2). Out of 40 clonal 
cell lines screened, we found two clonal cell lines that showed de-
letion in the sgRNA-targeted region in the Npc1 gene. These two 
independent cell lines with different deletion mutations (KO#1 
and KO#2) were expanded and used for functional analysis and 
used as Npc1-deficient (Npc1−/−) cells. Since both clonal cell 
lines gave identical results in inflammasome activation assays 
(Fig. 2), henceforth, we performed further research using only 
Npc1−/− #1 cells.
Filipin staining
Cells seeded at a density of 4 × 105 cells per well were grown on 
glass coverslips in a 24-well plate and incubated with U16888A 
overnight (iBMDMs) or for 48 h (BMDMs) to allow cholesterol 
accumulation. After desired treatments, cells were fixed in 4% 
paraformaldehyde for 1 h at room temperature. Cells were then 
stained with 25 µg/ml filipin (F9765; Sigma-Aldrich) overnight 
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and washed three times with PBS before mounting on glass 
slides. Images were visualized on an SP5 confocal microscope 
(Leica Microsystems) using 405-nm excitation lasers and pro-
cessed using ImageJ (National Institutes of Health).
Cholesterol supplementation assay
MCD (C4555; Sigma-Aldrich) and cholesterol (C8667; Sigma- 
Aldrich) complexes were prepared by diluting a 25 mg/ml stock 
solution of cholesterol 1,000-fold in serum-free DMEM contain-
ing 50 µM MCD and incubating at 50°C in a water bath for 2 h. 
Cells were plated into 12-well plates in the presence or absence 
of U18666a. On the day of the experiment, media were replaced 
with serum-free DMEM, and cells were primed with LPS (500 
ng/ml) for 3 h before replacing with 37°C prewarmed media con-
taining cholesterol–MCD complexes. Cells were then incubated 
for the indicated times before addition of 5 mM ATP for 45 min.
Exposure to statins
BMDMs were seeded into 24- or 12-well plates and incubated 
overnight in media containing 5% lipid-depleted serum (S181L; 
Biowest). The following morning, cells were stimulated with LPS 
(500 ng/ml) for 3 h before addition of fatostatin (40 µM; 4444; 
Tocris), lovastatin (40 µM; 1530; Tocris), or mevastatin (40 µM; 
1526; Tocris) for 1 h. For cholesterol restoration, media were re-
placed following statin treatment, and cells were recovered for 
2 h before addition of cholesterol for 1 h. ATP (5 mM) was then 
added for 45 min.
Immunoblotting and antibodies
For immunoblotting of casp-1, NLRP3, ASC, IL-1β, GSD MD, and 
GAP DH, cells were harvested at indicated time points in cell lysis 
buffer containing NP-40, DTT, and protease inhibitors (Roche). 
The samples were boiled at 95°C before resolving them on 12% 
SDS-PAGE gels. For phosphospecific immunoblotting, cells were 
exposed to 500 ng/ml LPS for different time points ranging from 
30 min to 4 h. Cell lysates were extracted in RIPA lysis buffer 
containing both protease and phosphatase inhibitors (Roche). 
Samples were placed on ice for 30 min before being centrifuged 
at 15,000 g for 15 min at 4°C to remove nuclei. The supernatant 
was then collected, and a 10-µl aliquot was used to measure pro-
tein concentration using the Pierce BCA Protein Assay Kit (23227; 
Thermo Fisher Scientific) according to the manufacturer’s in-
structions. The protein concentration of each sample was then 
normalized to 1 µg/ml with RIPA lysis buffer. Equal concentra-
tion of protein samples was resolved on 6–15% SDS-PAGE gels and 
then transferred to nitrocellulose membranes (GE Healthcare). 
Membranes were blocked for 1 h with 5% milk solution in TBS 
containing 0.05% Tween-20. Membranes were incubated in pri-
mary antibodies at 4°C overnight at the dilutions given below. 
HRP-conjugated secondary antibodies were used at room tem-
perature for 1 h. Proteins were visualized using the Clarity en-
hanced chemiluminescence substrate (1705060; Bio-Rad) or the 
Pierce enhanced chemiluminescence Western nlotting substrate 
(32209; Thermo Fisher Scientific). Images were taken on a Bio-
Rad imager and processed using the manufacturer’s software, 
Image Lab. The primary antibodies used were as follows: casp-1 
(1:2,000; AG-20B-0042-C100; AdipoGen), NLRP3 (1:2,000; 
AG-20B-0014-C100; AdipoGen), ASC (1:2,000; AG-25B-0006, 
AL177; AdipoGen), GSD MD (1:1,000; ab209845; Abcam), IL-1β 
(1:500; 12426; Cell Signaling Technology), AKT (1:1,000; 4691; 
Cell Signaling Technology), phospho-AKT (1:1,000; 4060; Cell 
Signaling Technology), p70-S6K1 (1:1,000; 2708; Cell Signaling 
Technology), phospho–p70-S6K1 (1:1,000; 9234; Cell Signaling 
Technology), and GAP DH (1:2,500; MA5-15738; Thermo Fisher 
Scientific). Secondary antibodies were obtained from Thermo 
Fisher Scientific and used at a dilution of 1:5,000.
Total and esterified cholesterol measurement
WT and Npc1−/− iBMDMs or primary mouse BMDMs were seeded 
into 12-well plates at a density of 106 per well. The following 
morning, the media were changed to LPDS media, and cells were 
stimulated with LPS (500 ng/ml) for 4  h. MCD samples were 
treated with 10 mM MCD for 30 min. Samples were then lysed in 
140 µl water for 30 min at 37°C before being used for cholesterol 
measurement. Total cholesterol was measured using the choles-
terol Amplex Red assay kit according to the manufacturer’s rec-
ommendations (A12216; Thermo Fisher Scientific). Unesterified 
cholesterol was measured by a slight modification of the original 
assay by omitting cholesterol esterase in the working reagent. 
Esterified cholesterol was calculated by subtracting the unester-
fied cholesterol from the total cholesterol levels for each sample 
tested in triplicate. Values were normalized to protein content, 
which was determined using a BCA protein assay (23225; Thermo 
Fisher Scientific).
PM cholesterol measurement
Cholesterol concentration of the PM was measured by a choles-
terol oxidase assay as previously described (Chu et al., 2015). WT 
and Npc1−/− iBMDMs were seeded into 24-well plates at a density 
of 0.5 × 106 per well. Cells were then treated with LPS and MCD 
as above. The cells were then washed three times with cold PBS 
followed by three washes with ice-cold assay buffer (310  mM 
sucrose [S0389; Sigma-Aldrich], 1 mM MgSO4 [M2643; Sigma- 
Aldrich], and 0.5 mM Na3PO4, pH 7.4 [342483; Sigma-Aldrich]). 
Cells were incubated with 500 µl assay buffer in the presence or 
absence of cholesterol oxidase (1 U/ml; C8649; Sigma-Aldrich) 
for 15 min at 37°C. Next, cells were washed with PBS followed by 
lysis in 90 µl of water for 30 min at 37°C. Total cholesterol was 
measured as above with the Amplex Red assay for each sample 
tested in triplicate. PM cholesterol was calculated by subtract-
ing cholesterol measurements for cells exposed to cholesterol 
oxidase (intracellular cholesterol) from measurements obtained 
from cells not exposed to cholesterol oxidase (total cholesterol). 
Values were normalized to protein content determined as above 
with a BCA assay.
RT-qPCR
RNA was isolated using TRIzol (T9424; Sigma-Aldrich) accord-
ing to the manufacturer’s instructions. The RNA pellet was 
suspended in 10 µl DNase/RNase-free water (Gibco). RNA con-
centration was measured in 2 µl RNA by NanoDrop, and 250 ng 
total RNA was reverse-transcribed into cDNA using the High Ca-
pacity cDNA Reverse Transcription kit (4368814; Applied Biosys-
tems). Real-time PCR was performed using gene-specific primers 
Journal of Cell Biology
https://doi.org/10.1083/jcb.201709057
de la Roche et al. 
ER sterol levels modulate the NLRP3 inflammasome
3574
and PowerUp SYBR Green (A25741; Applied Biosystems) and run 
on an ABI7500 or ABI7900HT (Applied Biosystems) fast real-time 
PCR instrument. The primers used are listed in Table S1.
Indirect immunofluorescence
WT and Npc1−/− cells seeded at a density of 4 × 105 cells per well 
were grown on glass coverslips in a 24-well plate and exposed 
to either U16888A or statin as described above. In some sam-
ples, MitoTracker Deep Red (Invitrogen) was added in OptiMEM 
media just before ATP stimulation. After desired treatments, 
cells were fixed in 4% paraformaldehyde for 30 min at room 
temperature. Cells were then labeled with the following primary 
antibodies for 1 h at room temperature: NLRP3 (1:200; AG-20B-
0014-C100; AdipoGen), Rabbit ASC (1:100; AG-25B-0006, AL177; 
AdipoGen), mouse ASC (1:100; 04-147, 2EI-7; EMD Millipore), 
and calreticulin (1:200; ab92516, EPR3924; Abcam). Secondary 
antibodies were all obtained from Thermo Fisher Scientific and 
used according to the manufacturer’s recommendations. Images 
were visualized and acquired on an SP5 confocal microscope and 
processed using ImageJ and the LAS AF program.
ELI SA
Cell culture supernatants were measured for IL-1β (88-7013-
88; eBioscience), IL-18 (7625; MBL), and TNF-α (88-7324-88; 
eBioscience) using ELI SA kits according to the manufactur-
er’s instructions.
LDH assay
LDH was measured in the cell culture supernatant using the 
Pierce LDH Cytotoxicity Assay Kit (88953; Thermo Fisher Scien-
tific) according to the manufacturer’s instructions.
Statistical analysis
GraphPad Prism 7.0 software was used for data analysis. Data are 
represented as mean ± SD or SEM and are representative of ex-
periments done at least three times. Statistical significance was 
determined by unpaired Student’s t test; P < 0.05 was considered 
statistically significant.
Online supplemental material
Fig. S1 shows lysosomal cholesterol accumulation upon U18666a 
treatment and that this does not affect the priming of the 
NLRP3 inflammasome. Fig. S2 shows the editing of Npc1 gene 
by CRI SPR-Cas9. Fig. S3 shows reduction in AKT–mTOR sig-
naling upon TLR4 ligation when NPC1 function is abrogated. 
Fig. S4 shows regulation of SRE BP2 and PM cholesterol lev-
els in Npc1−/− cells. Fig. S5 shows the localization of NLRP3 
and ASC speck in WT macrophages. Table S1 shows primers 
used for RT-qPCR.
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